[HTML][HTML] Site-specific proteasome inhibitors

AF Kisselev - Biomolecules, 2021 - mdpi.com
Proteasome is a multi-subunit protein degradation machine, which plays a key role in the
maintenance of protein homeostasis and, through degradation of regulatory proteins, in the …

[HTML][HTML] The proteasome and its role in the nervous system

F Türker, EK Cook, SS Margolis - Cell chemical biology, 2021 - cell.com
Proteasomes are multisubunit complexes that catalyze the majority of protein degradation in
mammalian cells to maintain protein homeostasis and influence the regulation of most …

[HTML][HTML] Proteasome inhibitors and their pharmacokinetics, pharmacodynamics, and metabolism

J Wang, Y Fang, RA Fan, CJ Kirk - International journal of molecular …, 2021 - mdpi.com
The proteasome is responsible for mediating intracellular protein degradation and
regulating cellular function with impact on tumor and immune effector cell biology. The …

[HTML][HTML] PA28γ: new insights on an ancient proteasome activator

P Cascio - Biomolecules, 2021 - mdpi.com
PA28 (also known as 11S, REG or PSME) is a family of proteasome regulators whose
members are widely present in many of the eukaryotic supergroups. In jawed vertebrates …

[HTML][HTML] A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis

S Dhar, S Gadd, P Patel, J Vaynshteyn, GP Raju… - Acta neuropathologica …, 2022 - Springer
Pediatric high-grade gliomas, specifically diffuse midline gliomas, account for only 20% of
clinical cases but are 100% fatal. A majority of the DMG cases are characterized by the …

Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms

S Sarroca, A Gatius, E Rodríguez-Farré… - The Journal of nutritional …, 2021 - Elsevier
Cumulative evidence indicates that excessive consumption of calories from saturated fat
contributes to the development of Alzheimer's disease (AD). Here, we assess the triggering …

[HTML][HTML] Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease

M Bi, X Du, X Xiao, Y Dai, Q Jiao, X Chen, L Zhang… - Redox biology, 2021 - Elsevier
Aberrant α-synuclein (α-Syn) accumulation resulting from proteasome dysfunction is
considered as a prominent factor to initiate and aggravate the neurodegeneration in …

[HTML][HTML] A library of cancer testis specific T cell receptors for T cell receptor gene therapy

MAJ de Rooij, DFG Remst, DM van der Steen… - Molecular Therapy …, 2023 - cell.com
To increase the number of cancer patients that can be treated with T cell receptor (TCR)
gene therapy, we aimed to identify a set of high-affinity cancer-specific TCRs targeting …

[HTML][HTML] At the cutting edge against cancer: a perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention

GR Tundo, D Sbardella, F Oddone, AA Kudriaeva… - Cancers, 2021 - mdpi.com
Simple Summary Immunoproteasome plays a key role in the generation of antigenic
peptides. Immune checkpoints therapy is a front-line treatment of advanced/metastatic …

Targeting immunoproteasome in neurodegeneration: A glance to the future

GR Tundo, P Cascio, D Milardi, AM Santoro… - Pharmacology & …, 2023 - Elsevier
The immunoproteasome is a specialized form of proteasome equipped with modified
catalytic subunits that was initially discovered to play a pivotal role in MHC class I antigen …